English | 繁體

Search in the results

UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Involvement of Bile Acid Metabolism and Gut Microbiota in the Amelioration of Experimental Metabolism-Associated Fatty Liver Disease by Nobiletin Journal article
Xu, Hongling, Yuan, Mingming, Niu, Kailin, Yang, Wei, Jiang, Maoyuan, Zhang, Lei, Zhou, Jing. Involvement of Bile Acid Metabolism and Gut Microbiota in the Amelioration of Experimental Metabolism-Associated Fatty Liver Disease by Nobiletin[J]. Molecules, 2024, 29(5), 976.
Authors:  Xu, Hongling;  Yuan, Mingming;  Niu, Kailin;  Yang, Wei;  Jiang, Maoyuan; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:4.2/4.6 | Submit date：2024/04/02
Bile Acid  Farnesoid x Receptor  Gut Microbiota  Metabolism-associated Fatty Liver Disease  Nobiletin  
Kaempferol acts on bile acid signaling and gut microbiota to attenuate the tumor burden in ApcMin/+ mice Journal article
Li, Xiaoyan, Khan, Imran, Huang, Guoxin, Lu, Yiyan, Wang, Liping, Liu, Yuanyuan, Lu, Linlin, Hsiao, W. L.Wendy, Liu, Zhongqiu. Kaempferol acts on bile acid signaling and gut microbiota to attenuate the tumor burden in ApcMin/+ mice[J]. European Journal of Pharmacology, 2022, 918.
Authors:  Li, Xiaoyan;  Khan, Imran;  Huang, Guoxin;  Lu, Yiyan;  Wang, Liping; et al.
Favorite | TC[WOS]:27 TC[Scopus]:27  IF:4.2/4.3 | Submit date：2022/09/21
Bile Acid (Ba)  Colorectal Cancer (Crc)  Farnesoid x Receptor (Fxr)  Gut Microbiota (Gm)  Kaempferol